Advertisement

Topics

Alpine Immune Sciences, Inc. Company Profile

12:10 EDT 22nd March 2019 | BioPortfolio

Alpine Immune Sciences, Inc. was founded in 2015 and is focused on developing novel protein‐based immunotherapies using its proprietary variant immunoglobulin domain (vIgD) platform technology. The vIgD platform is designed to create novel therapeutics that modulate multiple therapeutic targets, including many present in the immune synapse. Alpine's vIgDs are developed using a unique process known as directed evolution, which can produce proteins capable of either enhancing or diminishing an immune response and thereby may apply therapeutically to both oncology and inflammatory diseases. Alpine has also developed its transmembrane immunomodulatory protein (TIP™) technology, based on the vIgD platform, to enhance engineered cellular therapies. In October 2015, Alpine signed a worldwide research and license agreement with Kite Pharma, Inc. (NASDAQ: KITE) for up to $535 million in upfront and potential milestone payments and, in addition, royalties on resulting sales. The agreement allows Kite access to certain targets developed using Alpine's TIP platform. For more information visit www.alpineimmunesciences.com/.


News Articles [1460 Associated News Articles listed on BioPortfolio]

Alpine Immune treats first patient in Phase I trial of ALPN-101

Alpine Immune Sciences has commenced dosing of patients in a Phase I clinical trial of its investigational product ALPN-101 intended...Read More... The post Alpine Immune treats first patient in Phase...

Alpine Immune Sciences: A New Name On The Radar

Private placement brings in $25mm for Alpine Immune

Alpine Immune Sciences Inc. (multifunctional immunotherapies for cancer and autoimmune/inflammatory diseases) grossed $25mm through the private placement of 4.7mm common shares at $5.37 (an 8% premium...

Alpine Immune Sciences to Present at Two Upcoming Investor Conferences

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, to...

Alpine Immune Sciences: Digging Into A Recent Newcomer Onto The Immunotherapy Scene

Alpine Immune Sciences (ALPN) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow

$ALPN $25M Private Placement https://www.businesswire.com/news/home/20190116005269/en/Alpine-Immune-Sciences-Announces-25-Million-Private …

$ALPN $25M Private Placement https://www.businesswire.com/news/home/20190116005269/en/Alpine-Immune-Sciences-Announces-25-Million-Private …

Alpine Immune Sciences to Present at Ladenburg Thalmann 2018 Healthcare Conference

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, to...

PubMed Articles [2435 Associated PubMed Articles listed on BioPortfolio]

Cardiovascular effects and risks of recreational alpine skiing in the elderly.

Alpine skiing is one of the most popular recreational winter sports and attracts millions of tourists every year alone in the Alpine region. Several studies highlight the positive effects of alpine sk...

Analyzing the causes of alpine meadow degradation and the efficiency of restoration strategies through a mathematical modelling exercise.

As an important ecosystem, alpine meadow in China has been degraded severely over the past few decades. In order to restore degraded alpine meadows efficiently, the underlying causes of alpine meadow ...

Soil organic carbon and total nitrogen stocks in alpine ecosystems of Altun Mountain National Nature Reserve in dry China.

The Altun Mountain National Nature Reserve (AMNNR), characterized by complex topography, is located on the northern edge of the Qinghai-Tibetan Plateau. The stocks of soil organic carbon (SOC) and tot...

Human exposure to airborne pollen and relationships with symptoms and immune responses: Indoors versus outdoors, circadian patterns and meteorological effects in alpine and urban environments.

Pollen exposure is a major cause of respiratory allergies worldwide. However, it is unclear how everyday exposure is related to symptoms and how allergic patients may be affected spatially and tempora...

Changes in the soil microbial communities of alpine steppe at Qinghai-Tibetan Plateau under different degradation levels.

The alpine steppe at Qinghai-Tibetan Plateau is an important area for conserving water source and grassland productivity; however, knowledge about the microbial community structure and function and th...

Clinical Trials [3406 Associated Clinical Trials listed on BioPortfolio]

Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis

The objectives of this study are 1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Xience Xpedition™/Alpine™ ste...

10-years Nationwide Alpine Accidents in Austria

This observational study intends to analyze the characteristic of specific accidents happened in Austrian's mountainous regions. The mechanisms of accidents which are evaluated are lightni...

A 13-years Nationwide Study of Alpine Accidents in Austria

Brief Summary: This observational study intends to analyze the characteristic of specific accidents happened in Austrian's mountainous regions. The mechanisms of accidents which are evalu...

Alpine vs. Xpedition: Evaluation of Stent Delivery System

To evaluate and compare the performance of two stent delivery systems for percutaneous coronary intervention with everolimus-eluting stent.

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)

This study compares angiographic and clinical outcomes in patients with long coronary lesions treated with sirolimus-eluting stent (Ultimaster stent) or everolimus-eluting stent (Xience Al...

Companies [1593 Associated Companies listed on BioPortfolio]

Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. was founded in 2015 and is focused on developing novel protein‐based immunotherapies using its proprietary variant immunoglobulin domain (vIgD) p...

Alpine BioVentures

Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...

Alpine Investors

Alpine Investors is a values-driven private equity firm committed to building enduring, purpose-driven companies through its unique PeopleFirst model. Leading with a focus on peop...

Alpine Biomed Corporation

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux diseas...

Alpine SG

Alpine SG, LLC (“ASG”) is a group of market-leading vertical SaaS companies, backed by Alpine Investors and operated by world-class PeopleFirst™ leaders. ASG believ...

More Information about "Alpine Immune Sciences, Inc." on BioPortfolio

We have published hundreds of Alpine Immune Sciences, Inc. news stories on BioPortfolio along with dozens of Alpine Immune Sciences, Inc. Clinical Trials and PubMed Articles about Alpine Immune Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alpine Immune Sciences, Inc. Companies in our database. You can also find out about relevant Alpine Immune Sciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record